Descriptive statistics were used to compare groups at enrollment and antiretroviral therapy (ART) initiation over time. The proportion of adolescents was compared with the total number of individuals aged 10 years and older enrolling over time. Competing-risk analysis was used to estimate 12-month attrition after enrollment/pre-ART initiation; post-ART attrition was estimated by KaplanMeier method. Conclusions: Expanding HIV services and ART coverage was likely associated with earlier adolescent enrollment and ART initiation but also with higher attrition rates before and after ART initiation. Interventions are needed to promote retention in care among adolescents.
INTRODUCTION
Adolescents living with HIV are a priority population in addressing the global HIV epidemic. 1, 2 The major burden of HIV among adolescents exists in sub-Saharan Africa, where 85% of the estimated 2 million global HIV-infected adolescents live, and where 92% of global AIDS-related adolescent deaths occur. [3] [4] [5] Although new HIV infections and AIDSrelated deaths have declined overall in sub-Saharan Africa, HIV remains the leading cause of death among adolescents 10-19 years of age in the region. 3, 6 Furthermore, the World Health Organization (WHO) estimated a 50% increase in the incidence of AIDS-related deaths among adolescents from 2005 to 2012, compared with a 32% decrease among other age groups. 4, 7 Despite the broad scale-up of HIV services that includes expanded antiretroviral therapy (ART) coverage and eligibility that occurred over this timeframe, few studies describe how the characteristics of adolescents enrolling in HIV care and initiating ART have changed over the years. 6 Understanding these characteristics is important because adolescents face multiple challenges in navigating the HIV care and treatment cascade. Limited awareness of HIV infection, inadequate access to testing and counseling services, and low uptake of these services lead to delayed care entry and more advanced disease stage at enrollment in care. 1, [8] [9] [10] [11] Multiple studies in sub-Saharan Africa have reported higher attrition for adolescents both before and after ART initiation when compared with adults, and poor adherence to ART and attrition have both been associated with worse virologic outcomes and higher mortality compared with adults. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Many of these studies report aggregate data or are limited by small sample sizes. 4 As such, they do not allow us to address the distinct developmental and social differences between younger and older adolescents, who may have different modes of HIV acquisition and risks of adverse outcomes. Moreover, many studies are cross-sectional and limited in their ability to extrapolate epidemiologic trends to evaluate and contextualize public health interventions, or sample from few geographic locations with potentially limited generalizability. 4 As of 2014, Kenya, Tanzania, and Uganda together accounted for 33% of HIV-infected adolescents aged 10-19% and 31% of AIDS-related adolescent deaths in Eastern and Southern Africa. 24 The population of HIV-infected adolescents in these and other global regions is expected to grow over the coming years, given the increasing survival of perinatally infected children, the contribution of new sexually transmitted infections, and the projected increase in the absolute number of adolescents in living in low-income countries. 4, 25 Achieving the Joint United Nations Programme on HIV/AIDS 90-90-90 targets for this vulnerable population will require robust data concerning the epidemiologic patterns of adolescents enrolling in HIV care and initiating ART. 6, 26 The objective of this study is to understand the characteristics and outcomes over time of adolescents enrolling in HIV care and initiating ART in Kenya, Tanzania, and Uganda using data from the East Africa (EA) International Epidemiology Databases to Evaluate AIDS (IeDEA) Consortium.
METHODS

Study Design
This retrospective cohort used data of prospectively enrolled HIV-infected adolescents attending HIV care programs affiliated with the EA-IeDEA Consortium. The study was approved under the EA-IeDEA by the Indiana University IRB and all local regulatory bodies affiliated with each participating site. Patient-level consent was waived by all regulatory bodies because the data were collected as part of routine clinical care and were deidentified before data transfer and analysis.
Study Setting
This study was conducted at 6 HIV care programs in Kenya, Tanzania, and Uganda that participate in EA-IeDEA, an NIH-funded consortium that pools and harmonizes patient data collected in the context of routine care. Descriptions of the study sites can be found elsewhere. 27, 28 All facilities provided standard-of-care HIV treatment services as per their respective local and national guidelines. None of the facilities during the period of study offered Adolescent Clinics. With the exception of Moi Teaching and Referral Hospital at the Academic Model Providing Access to Healthcare (AM-PATH) program in Kenya, all children were seen in the same clinic as adults; however, at times, there was a dedicated clinic day for children when a consultant might be present to support the regular providers, and care was not transitioned. At this clinic, adolescents were commonly seen in the pediatric clinic into their 20s. The study population included all adolescents who were between 10 and 19 years of age, inclusive, at the time of enrollment in HIV care at one of the participating programs between 2001 and 2014.
Data Management
At each facility, demographic and clinical data were collected on paper-based forms completed by clinicians during the course of routine clinical care. Forms were then transcribed into the local electronic medical record system by trained data entry clerks. Data quality assessments were performed according to local protocols for each facility. Data were transferred biannually to the IeDEA-EA Regional Data Center where they were merged, and additional data quality assessments were undertaken before data were submitted for analysis.
Data Analysis
Adolescence was defined as ages 10-19 years to be consistent with the WHO and United Nations definition of adolescence. 3, 29 Adolescents were stratified into 2 groups based on age at the time of enrollment in HIV care: younger adolescents (10-14 years) and older adolescents (15-19 years) . Patient-level, independent variables included the following: (1) demographic characteristics: sex, age, and pregnancy status at enrollment, and (2) clinical characteristics: WHO clinical stage at enrollment and at ART initiation, CD4 count at enrollment and at ART initiation, receipt of pneumocystis pneumonia prophylaxis, or isoniazid prophylaxis for tuberculosis. For all post-enrollment variables, the follow-up time was constructed such that younger adolescents were censored on reaching age 15, and older adolescents were censored on their 20th birthday. Outcome variables included incident pregnancy and TB diagnosis, which excluded prevalent pregnancy and TB cases, and were reported in person-year incidence rates to account for differences in observation time between adolescents in each group. To assess the changes in characteristics and retention for younger and older adolescents at enrollment and ART initiation over time, the study timeframe was divided into 4 enrollment periods: 2001-2004, 2005-2009, 2010-2012, and 2013-2014 . The first period occurred before the introduction of the United States President's Emergency Plan for AIDS Relief (PEPFAR) program while the remaining periods align with the WHO guideline changes for ART eligibility. 30, 31 The characteristics of younger and older adolescents enrolling within each of these periods were summarized with standard descriptive analyses. The proportion of enrolling adolescents was compared with the total number of individuals aged 10 years and older enrolling during each period. The CochranArmitage linear trend test was used for categorical variables to assess the presence of association and detect trends across periods for younger and older adolescents; the KruskalWallis test was used for continuous variables. All P values were two-tailed with a value ,0.05 considered statistically significant.
Program attrition at 12 months after enrollment but before ART initiation, and at 12 months after ART initiation, was analyzed in each enrollment period. For this analysis, younger adolescents who reached their 15th birthday and older adolescents who reached their 20th birthday but who had not attained 12 months of follow-up were not censored at their date of birth. Attrition was defined as the composite outcome of death and loss to follow-up (LTFU). LTFU was defined as having no clinic visits for 90 days after the last scheduled clinic appointment and not having been recorded as dead or transferred out before the 12-month endpoint. 27 Competing-risk estimation was used to estimate attrition incidence after enrollment but before ART initiation, where ART initiation was treated as a competing risk. Cumulative incidence of attrition was calculated by the Aalen-Johansen estimator. Attrition after ART initiation was calculated using the Kaplan-Meier method. Cumulative incidence of attrition was estimated as one minus the Kaplan-Meier estimate of the probability of retention. Cumulative incidences were compared between groups using the Gray test. 32 In both cases, 95% confidence intervals were produced by these methods. Landmark values of attrition at 12 months after enrollment and ART initiation, with attendant 95% confidence intervals, were also produced. Follow-up time was determined by the Kaplan-Meier method with end of follow-up being the event of interest and program attrition considered a censoring event.
RESULTS
Characteristics at Enrollment and ART Initiation
A total of 6344 adolescents aged 10-19 years were enrolled into care from November 27, 2001, through December 10, 2014 ( Table 1 ). The total number of adolescents enrolled across programs ranged from 142 adolescents (2.2% of total cohort) in Rakai, Uganda, to 3845 adolescents (60.6% of total cohort) at AMPATH, Kenya. Overall, 3241 (51.1%) were younger adolescents, and younger adolescent enrollment exceeded older adolescent enrollment in over half of the facilities. Two-thirds (67.2%) of all adolescents were female, with girls accounting for 55.4% of younger and 79.5% of older adolescents. The prevalence of tuberculosis at enrollment was 3.5% for younger and 1.4% for older adolescents. Among those with available WHO stage at enrollment, the majority (71.2%) had WHO stage 1 or 2, including 63.0% of younger and 78.9% of older adolescents. Among those with available WHO stage at ART initiation, 46.2% and 64.2% of younger and older adolescents, respectively, had WHO stage 1 or 2 at ART initiation.
Clinical Events while Enrolled
The median follow-up period for younger adolescents was 5.0 years (95% confidence interval: 4.6 to 5.4) and 2.1 years (95% confidence interval: 1.9 to 2.3) for older adolescents estimated by Kaplan-Meier analysis. The incidence of first pregnancy after enrollment was 6 cases per 100,000 person-years for younger and 100 per 100,000 person-years for older female adolescents. The incidence of 
Characteristics Over Time
From 2001 to 2014, the proportion of adolescents among all individuals aged 10 years and older enrolling at the study facilities increased from 2.5% in 2001-2004% to 3.9% in 2013-2014 ( Fig. 1; P , 0.0001) . During the same period, the proportion of older adolescents enrolling into care increased from 0.9% to 2.6% (P , 0.0001). The proportion of female adolescents also increased over time for younger (47.1%-60.8%, P = 0.003) and older (70.7%-82.7%, P = 0.001) adolescents ( Table 2 ). The percentage of younger and older adolescents who received pneumocystis pneumonia prophylaxis increased over time, from 83.0% to 98.3% for younger (P , 0.0001) and 56.1%-99.9% for older (P , 0.0001) adolescents from 2001-2004 to 2013-2014, respectively. Over the same periods, the percentage who received isoniazid prophylaxis for tuberculosis decreased for younger (10.5%-2.6%, P , 0.0001) and older (29.3%-3.6%, P , 0.0001) adolescents.
Overall, both younger and older adolescents had less advanced HIV disease at enrollment and at ART initiation in more recent periods (Table 2 and Fig. 2 (Table 2) . For older adolescents, the proportions with missing WHO stage ranged from 23.4% to 36.6% at enrollment and 22.6%-33.3% at ART initiation. Statistical analysis for WHO stage differences between groups and over time was not performed given the high proportion of missing data.
The cumulative incidence estimates of 12-month attrition after enrollment/pre-ART initiation significantly increased over time among all adolescents, from 2.6% in 2001-2004 to 8.7% in 2013-2014 (P , 0.001; Table 3 ). After ART initiation, 12-month attrition among all adolescents also increased over the same periods, from 18.7% to 31.2% (P , 0.001). Attrition estimates after enrollment/pre-ART initiation and after ART initiation were significantly higher for older compared with younger adolescents in all periods except 2013-2014.
DISCUSSION
This study presents the trends over time for adolescents enrolling in HIV care and initiating ART at HIV care programs in Kenya, Tanzania, and Uganda. We found that the proportion of older adolescents enrolling among all enrollees aged 10 years and older significantly increased from 0.9% in 2001-2004% to 2.6% in 2013-2014. Although adolescents accounted for a low proportion of individuals aged 10 years and older enrolling overall, the proportion of older adolescents increased nearly threefold over the study timeframe, whereas the proportion of younger adolescents was stable or slightly declined over the same periods. This finding highlights the importance of disaggregating adolescent data by age to better understand programmatic and epidemiologic trends in the population of adolescents living with HIV. Ongoing tracking of age-and sex-disaggregated enrollment data for adolescents in East Africa will be needed to contextualize the potential impact of HIV prevalencemodifying influences in the region [eg, prevention of motherto-child transmission (PMTCT) program expansion, increasing HIV knowledge and prevention behaviors, and increasing HIV testing and counseling programs]. 24 Our study also suggests that the proportion of adolescents enrolling in care and initiating ART with advanced HIV disease has decreased markedly over time. It has been reported elsewhere that progressive decentralization and expansion of HIV testing and counseling, including homebased testing and enrollment through PMTCT services, have likely contributed to earlier enrollment of adolescents. 8, [33] [34] [35] In another EA-IeDEA analysis, pregnant women aged 13 years and older were found to comprise an increasing proportion of those initiating ART from 2004-2014, even before the expansion of ART eligibility through Option B+. 36 However, overall decreases in the proportion of individuals starting treatment with WHO stage 3/4 disease over time were primarily attributable to nonpregnant women and men rather than pregnant women. Earlier ART initiation may also reflect earlier enrollment, as well as higher national CD4-based ART eligibility thresholds, better treatment of sicker individuals, and increasing care capacity and ART access for HIV programs in the region over time. 11, 35, 37, 38 Our data, which are largely descriptive in nature, cannot directly address these issues, but the observed trends are consistent with the aforementioned studies and add to the growing volume of studies showing the association of ART scale-up and contemporary patient trends in our region. 39 The increase in median CD4 count at enrollment further suggests that horizontally infected adolescents are seeking care earlier, which may also be contributing to the increasing enrollment of older adolescents. This may also include younger adolescents with horizontally acquired infections, as population data from Kenya, Tanzania, and Uganda indicate 9%-12% of boys and 12%-22% of girls have had sex before the age of 15. 5 Importantly, median CD4 counts at ART initiation throughout our study remained below 350 cells per microliter for younger and older adolescents despite the 2009 recommendation that ART be initiated at this CD4 threshold irrespective of clinical symptoms. 31 Continued increases in CD4 counts at enrollment and ART initiation are anticipated in the future with broader HIV testing and adoption of universal treatment guidelines. Finally, we found that attrition significantly increased over time for all adolescents and was nearly twice as high among older compared with younger adolescents in all periods except 2013-2014. These findings emphasize the importance of addressing adolescent attrition, particularly among older adolescents, within HIV programs in our region. 3 . Changing programmatic or facility characteristics (including implementation of pediatric-focused clinics and service delivery), treatment guidelines, poor patient tracing amidst increasing adolescent enrollment, or changing demographic and clinical characteristics (eg, HIV disease stage) of adolescents enrolling in HIV care, may also account for the estimated increases in attrition over time in our study. That attrition was higher for older compared with younger adolescents, is consistent with other studies, and FIGURE 2. Median CD4 count for younger, older, and total (labeled) adolescents at enrollment and ART initiation across periods. All values were significantly different from one another across periods (P , 0.0001). likely reflects the increased autonomy experienced by older adolescents during their transition to adulthood as well as differences in care and treatment approaches by providers as adolescent age. 11, [21] [22] [23] 34 Within this study, we are unable to address the issues surrounding transition during adolescents because the clinics represented during the study period did not have standardized practices for transition. However, we have an ongoing study of transitioning and will be able to address this in a future article. Transition of care for adolescents and youth has emerged as a key issue that involves increasing roles and responsibilities for adolescents as they navigate developmental and psychosocial changes, as well as changes in health care providers and care structure. 40 Data to understand transition outcomes and optimal models of transition are limited in sub-Saharan Africa. Adolescentfocused services and staff that include peer and psychosocial support are likely required, and existing transition policies need to be implemented. [40] [41] [42] [43] [44] Reducing attrition among adolescents enrolling in HIV care in our region will also require a better understanding of LTFU (ie, as unidentified mortality, silent transfer, or complete disengagement from care), as well as a deeper grasp of the individual-, social-, and facility-level factors that influence attrition. 27, 43 Our data have several strengths but also significant limitations. A strength of this study is its longitudinal focus on adolescent care across multiple high-and low-volume facilities serving adolescents in East Africa. Our study provides a broad picture of the evolving HIV epidemic among adolescents that may serve as a benchmark against which future research can be evaluated. The use of routine program data to understand adolescent characteristics at enrollment and post-ART initiation phases of care is both a strength, as our data is likely to reflect typical care environments in East Africa, and limitation, as reliance on routine program data resulted in missing WHO stage in a high proportion of adolescents. This limitation is consistent with other adolescent studies using routinely collected data in subSaharan Africa. 11, 21, 23, 35 Our study also included a limited number of HIV facilities across East Africa, which may not be generalizable to the region as a whole, particularly given the variability in resources and HIV services that exist within and between countries. Finally, our attrition results may have been affected by overestimation of LTFU (eg, because of undocumented transfer). 45 Although, LTFU among patients with generally less advanced HIV disease suggests that most of the program attrition is caused by disengagement from care rather than death. This limitation underscores the importance of understanding the causes of LTFU to accurately understand program attrition. 46 Finally, it is important to recognize that our findings are not disaggregated by sex, and there remains a paucity of gender-disaggregated retention data and for adolescents in sub-Saharan Africa. [47] [48] [49] [50] Two studies did not identify sex differences in adolescent LTFU, whereas 1 in South Africa identified higher retention among male adolescents attending adolescent-friendly clinics. [51] [52] [53] This contrasts with multiple studies among adults in sub-Saharan Africa that have found higher LTFU among male adolescents compared with female adolescents. [54] [55] [56] Given the significant developmental and psychosocial changes that occur during adolescence, which can affect male and female adolescents differently, research in this area is critically needed. Stigma, disclosure, depression, and other stressors may be experienced and coped with differently by each sex. [57] [58] [59] Pregnancy may also jeopardize retention among female adolescents. In a related EA-IeDEA study, the risk of LTFU was nearly twice as high for pregnant compared with nonpregnant female adolescents. 60 Moreover, attrition during PMTCT follow-up is alarmingly common. 57, 61 Future studies are needed to explore the sexspecific factors that influence retention and adherence, both to more sharply define and track the adolescent HIV epidemic, and to develop more appropriately targeted interventions in program design, policy, and advocacy for adolescents.
CONCLUSIONS
Earlier enrollment and ART initiation occurred over time for adolescents in East Africa, likely influenced by the scale-up of HIV testing, ART coverage, and national guidelines recommending earlier ART initiation in the region. However, attrition also increased over time for younger and older adolescents, emphasizing the need for additional efforts to address and define the factors and interventions that promote retention among adolescents, particularly for those aged 15 years and older. Future longitudinal analyses will be needed to track the evolving HIV epidemic among adolescents in East Africa.
